Dr. Edward Scott Gronka, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 874 W Lanier Ave, One Prestige Park Suite 100, Fayetteville, GA 30214 Phone: 770-461-4000 Fax: 770-461-2790 |
Dr. Joel M Stewart Jr., M.D. Plastic Surgery - Plastic Surgery Within the Head and Neck Medicare: Accepting Medicare Assignments Practice Location: 874 Lanier Ave W, Suite 100, Fayetteville, GA 30214 Phone: 770-714-7802 Fax: 770-714-7802 |
Dr. Paul David Feldman, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 874 W Lanier Ave, Suite 100, Fayetteville, GA 30214 Phone: 770-461-4000 Fax: 770-461-2790 |
Dr. Joseph Raniere,jr, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 874 W Lanier Ave, One Prestige Park Suite 100, Fayetteville, GA 30214 Phone: 770-461-4000 Fax: 770-461-2790 |
News Archive
An international team that includes NIH-funded researchers at Stanford University has developed a therapeutic compound that is effective in inhibiting Plasmodium falciparum, one of five species of parasite that infects people with malaria, and the strain which causes the highest number of malaria deaths.
Researchers at Southern Methodist University in Dallas have developed a concise new explanation for the basic mechanics involved in human running.
A survey of 337 retirees on Medicare revealed that 45% believe the economy is the most critical issue facing America in 2012 - beating out the national debt (21%); jobs (19%); and health care (15%) for the top spot.
Canadian researchers have determined that community-based pharmacists could provide an added resource in identifying knee osteoarthritis (OA). The study, published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), represents the first evidence supporting a collaborative approach to managing knee OA.
Taiho Pharmaceutical Co., Ltd. (Tokyo, President: Masayuki Kobayashi) announced on March 24 that it has obtained approval in Japan from the Ministry of Health, Labour and Welfare to manufacture and market the oral combination anticancer drug "Lonsurf(R) combination tablet T15, T20" (nonproprietary names: trifluridine and tipiracil hydrochloride; development code: TAS-102), for the treatment of patients with unresectable advanced or recurrent colorectal cancer (only if refractory to standard therapies).
› Verified 2 days ago